Amerisource
7 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Amerisource and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-05-27FDA-DrugClass IIIAmerisource Primidone Tablets recalled for contamination
Amerisource Health Services has recalled certain batches of Primidone Tablets, USP, 50 mg due to cross-contamination during manufacturing. The tablets contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, which should not be present in this medication.
- 2026-05-27FDA-DrugClass IIIAmerisource Primidone tablets recalled for cross-contamination
Primidone tablets distributed by American Health Packaging were found to contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, due to cross-contamination during manufacturing. The affected lot (1027583, expiring 09/30/2027) contains approximately 63,500 tablets distributed nationwide. No injuries have been reported.
- 2026-04-01FDA-DrugClass IIStop using recalled Meclizine Hydrochloride tablets
American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.
- 2026-02-18FDA-DrugClass IICheck your oxycodone tablets for loose packaging
American Health Packaging is recalling certain oxycodone hydrochloride 5 mg tablets because the blister card seals are defective or missing. This allows tablets to fall out of their compartments. The recall affects 31,676 packages distributed nationwide with specific lot numbers and expiration dates.
- 2025-11-05FDA-DrugClass IIPrazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 60687-572-32, Individual unit dose: NDC 60687-572-33
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
- 2025-11-05FDA-DrugClass IIPrazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-997-01, Individual unit dose: NDC 68084-997-11
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
- 2025-11-05FDA-DrugClass IIPrazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-996-01. Individual unit dose: NDC 68084-996-11
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Get notified about new Amerisource recalls
Free weekly digest. We email when a new federal recall affects Amerisource or anything else in your household.
Get the Sunday Brief